Antidepressant effects of fibroblast growth factor-2 in behavioral and cellular models of depression
about
A New Outlook on Mental Illnesses: Glial Involvement Beyond the GlueAstrocyte pathology in major depressive disorder: insights from human postmortem brain tissueGlial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity?Animal models of sports-related head injury: bridging the gap between pre-clinical research and clinical realityRapid antidepressant actions of scopolamine: Role of medial prefrontal cortex and M1-subtype muscarinic acetylcholine receptorsGABA interneurons mediate the rapid antidepressant-like effects of scopolamine.Allosteric Modulation of Sigma-1 Receptors Elicits Rapid Antidepressant ActivityFunctional role of adult hippocampal neurogenesis as a therapeutic strategy for mental disordersQuantitative assessment of fibroblast growth factor receptor 1 expression in neurons and glia.Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome.-Glial and stem cell expression of murine Fibroblast Growth Factor Receptor 1 in the embryonic and perinatal nervous systemFGF2 is a target and a trigger of epigenetic mechanisms associated with differences in emotionality: partnership with H3K9me3.Antidepressant acts on astrocytes leading to an increase in the expression of neurotrophic/growth factors: differential regulation of FGF-2 by noradrenalineThe Effects of Stress Exposure on Prefrontal Cortex: Translating Basic Research into Successful Treatments for Post-Traumatic Stress Disorder.Antidepressant-like effects of erythropoietin: a focus on behavioural and hippocampal processes.Neurotrophic factor-α1 prevents stress-induced depression through enhancement of neurogenesis and is activated by rosiglitazone.How animal models inform child and adolescent psychiatry.Fibroblast growth factor-2: an endogenous antidepressant and anxiolytic molecule?Fibroblast growth factor 9 is a novel modulator of negative affect.The fibroblast growth factor family: neuromodulation of affective behavior.Ketamine produces antidepressant-like effects through phosphorylation-dependent nuclear export of histone deacetylase 5 (HDAC5) in rats.Abnormal fatty acid composition in the frontopolar cortex of patients with affective disordersVentral tegmental area muscarinic receptors modulate depression and anxiety-related behaviors in rats.Interplay between pro-inflammatory cytokines and growth factors in depressive illnessesThe chronic mild stress (CMS) model of depression: History, evaluation and usageMolecular and Cellular Mechanisms of Rapid-Acting Antidepressants Ketamine and ScopolamineFibroblast growth factors in neurodevelopment and psychopathology.Dysregulated fibroblast growth factor (FGF) signaling in neurological and psychiatric disorders.Neural stem cells and neuro/gliogenesis in the central nervous system: understanding the structural and functional plasticity of the developing, mature, and diseased brain.Effects of [Nphe1, Arg14, Lys15] N/OFQ-NH2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress.Brain-network mechanisms underlying the divergent effects of depression on spontaneous versus evoked pain in rats: a multiple single-unit study.Ketamine and Imipramine Reverse Transcriptional Signatures of Susceptibility and Induce Resilience-Specific Gene Expression Profiles.Enzymatic Depletion of the Polysialic Acid Moiety Associated with the Neural Cell Adhesion Molecule Inhibits Antidepressant Efficacy.Cariprazine Exhibits Anxiolytic and Dopamine D3 Receptor-Dependent Antidepressant Effects in the Chronic Stress Model.Genetic and Stress-Induced Loss of NG2 Glia Triggers Emergence of Depressive-like Behaviors through Reduced Secretion of FGF2.Dynamic modulation of basic Fibroblast Growth Factor (FGF-2) expression in the rat brain following repeated exposure to cocaine during adolescence.Dysregulation of vitamin D metabolism in the brain and myocardium of rats following prolonged exposure to dexamethasone.Anxiolytic effects of muscarinic acetylcholine receptors agonist oxotremorine in chronically stressed rats and related changes in BDNF and FGF2 levels in the hippocampus and prefrontal cortex.Fibroblast growth factor 2 regulates activity and gene expression of human post-mitotic excitatory neurons.Oligodendroglia-lineage cells in brain plasticity, homeostasis and psychiatric disorders.
P2860
Q26770756-4A16F1A1-A41D-42C2-9136-E708DFF3B8F7Q26827833-420F4DD0-431F-45C0-95A2-48961C602774Q26829556-FBDE45C1-8A67-4188-A3F8-FD529B886107Q26995674-D5D1D968-1D5B-436C-B04D-0E823A366C48Q27308009-017FBFDB-8F7E-470D-88A0-4FF3D48BB522Q27329758-FCDDB339-5C00-4421-B954-008DE27D27A8Q28273055-548ABADA-5732-4483-A1BD-A46ED4F32A68Q30458969-B8603E2F-0FB5-4039-BB3A-DFCFD51D7753Q33583690-5CC32786-2464-470C-8B6D-A9F54D7A55BDQ33635571-FFE54632-7DC3-4337-972C-4FCC10F64DB0Q33862117-98CCADE7-8838-416A-B5A1-471CA82C0227Q34060622-AC0A38B5-30EA-4F09-86C8-62E1E78697A6Q34507303-9587CC8F-5BE5-4603-AC31-43BAD304AC92Q34571585-D1B55F43-0762-4286-AB3B-531465641EA9Q34982719-FE1820C1-0C9C-44C5-8D80-3A0FF9AF881EQ35513093-4BC689CF-F3AC-418E-B091-0F8AB430F71FQ35529375-5B09BDFD-004B-4494-8CE9-6B8F7D307D46Q35563970-E5772740-337B-4636-994B-FA964859BA46Q36103079-3D5C90B5-B750-4DAD-A5F8-C0F3780FF0C1Q36334413-84A573F3-B623-4A46-A9E6-DE2DD39E04DEQ36419883-C3817B5D-3AB8-45E9-91DF-7517F5A7EE97Q36589684-35DB4CC7-DD86-42A0-BF85-F9555239F6E2Q36703335-5B748D1A-7D05-474F-8A92-BB3B6739F5AEQ36832872-98BCFC74-8731-4817-A01A-02282DF5A4F6Q37648894-2B9C6EE0-9D0E-4369-B350-A981AC495F98Q37668009-2C426B31-609B-421A-A355-8D5729A5E802Q38076267-FE0EDB2B-C016-461A-AAEB-E864A1A54743Q38603624-66DF0810-1C43-448D-9CE5-3B752DC5CC4BQ38636602-0799EB49-DB06-4384-9BD6-6830B878375EQ38833155-66456639-CFCD-4324-9CB7-A1704D946458Q39293602-B6D030A3-4216-4AF8-B92E-BE406299EC9BQ39296220-BF338557-78F9-4B12-99F9-287D2A765F56Q40184448-DE49A92B-A526-4304-B728-9E511930DF05Q42141320-9505695E-1704-48F0-B97C-89110917BF2FQ42315823-2980CB8A-8794-4C6E-98FC-80D7AAAEDAC7Q43789460-03F6BAA2-C65A-4FAF-AA62-A611ADA60F02Q44538830-9F4C3D02-E1D1-472C-80EB-93251CB669A3Q47363556-0BA03F90-21BC-4F11-9E9D-77BB8B5DB4CFQ47698740-99C590B7-2EB3-4AC0-A20B-568BC2C98C8DQ47999805-067FBBDA-A69B-46C6-A8B4-0E8674F57143
P2860
Antidepressant effects of fibroblast growth factor-2 in behavioral and cellular models of depression
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Antidepressant effects of fibr ...... cellular models of depression
@ast
Antidepressant effects of fibr ...... cellular models of depression
@en
type
label
Antidepressant effects of fibr ...... cellular models of depression
@ast
Antidepressant effects of fibr ...... cellular models of depression
@en
prefLabel
Antidepressant effects of fibr ...... cellular models of depression
@ast
Antidepressant effects of fibr ...... cellular models of depression
@en
P2093
P2860
P1476
Antidepressant effects of fibr ...... cellular models of depression
@en
P2093
Maha Elsayed
Mounira Banasr
Neil M Fournier
Pawel Licznerski
Ronald S Duman
Vanja Duric
P2860
P304
P356
10.1016/J.BIOPSYCH.2012.03.003
P407
P577
2012-04-17T00:00:00Z